Literature DB >> 20582247

Sex differences in visceral adipose tissue post-bariatric surgery compared to matched non-surgical controls.

J Korner1, M Punyanitya, C Taveras, D J McMahon, H J Kim, W Inabnet, M Bessler, D Gallagher.   

Abstract

OBJECTIVE AND METHODS: Given the profound weight loss after gastric banding and bypass we compared fat compartmentalization by whole body magnetic resonance imaging in women and men after these procedures to two groups of non-surgical controls who were either matched for age, weight and height or were of lower body mass index (BMI). RESULT: In women post-surgery (n=17; BMI 31.7 kg/m(2)) there was lower visceral adipose tissue (VAT) (1.4 vs 2.5 kg; P<0.01) compared with matched controls (n=59; BMI 32.1 kg/m(2)). In contrast, VAT (5.3 vs 5.4 kg) was nearly identical in men post-surgery (n=10; BMI 34.1 kg/m(2)) compared with matched controls (n=10; BMI 32.1 kg/m(2)) even though the degree of weight reduction was not significantly different from women (27.4 vs 32.6%). Furthermore, VAT when adjusted for total adipose tissue (TAT) was 43% less in women post-surgery (1.2 vs 2.1 kg; P=0.03) than in controls with lower BMI (25.1 kg/m(2)). After adjustment for TAT, subcutaneous adipose tissue in women post-surgery was significantly greater than matched controls (35.1 vs 34.2 kg; P=0.03). There was a significant negative correlation of VAT and the degree of weight loss in women (r=-0.57; P=0.018) but this relationship was not significant in men (r=-0.39; P=0.27). Skeletal muscle was lower in both sexes compared with matched controls (women, 21.8 vs 23.1 kg; men, 32.5 vs 35.5 kg).
CONCLUSION: Prospective studies are necessary to confirm if there is a sexual dimorphism in the effects of bariatric surgery on body composition.

Entities:  

Year:  2008        PMID: 20582247      PMCID: PMC2892292     

Source DB:  PubMed          Journal:  Int J Body Compos Res        ISSN: 1479-456X


  39 in total

1.  The early effects of weight loss surgery on regional adiposity.

Authors:  Madeleine L Phillips; Mark C Lewis; Veronica Chew; Lilian Kow; John P Slavotinek; Lynne Daniels; Robin Valentine; Jim Toouli; Campbell H Thompson
Journal:  Obes Surg       Date:  2005 Nov-Dec       Impact factor: 4.129

Review 2.  Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery.

Authors:  David E Cummings; Joost Overduin; Karen E Foster-Schubert; Molly J Carlson
Journal:  Surg Obes Relat Dis       Date:  2007 Mar-Apr       Impact factor: 4.734

3.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

Authors:  Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

4.  Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial.

Authors:  Torsten Olbers; Sofia Björkman; Ak Lindroos; Almantas Maleckas; Lars Lönn; Lars Sjöström; Hans Lönroth
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

Review 5.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

6.  Effects of gender, body composition, and menopause on plasma concentrations of leptin.

Authors:  M Rosenbaum; M Nicolson; J Hirsch; S B Heymsfield; D Gallagher; F Chu; R L Leibel
Journal:  J Clin Endocrinol Metab       Date:  1996-09       Impact factor: 5.958

7.  Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels.

Authors:  Judith Korner; William Inabnet; Irene M Conwell; Carmen Taveras; Amna Daud; Lorraine Olivero-Rivera; Nancy L Restuccia; Marc Bessler
Journal:  Obesity (Silver Spring)       Date:  2006-09       Impact factor: 5.002

8.  Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance.

Authors:  D E Kelley; F L Thaete; F Troost; T Huwe; B H Goodpaster
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-05       Impact factor: 4.310

Review 9.  Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk.

Authors:  Richard N Bergman; Stella P Kim; Isabel R Hsu; Karyn J Catalano; Jenny D Chiu; Morvarid Kabir; Joyce M Richey; Marilyn Ader
Journal:  Am J Med       Date:  2007-02       Impact factor: 4.965

10.  Sex differences in the relation of visceral adipose tissue accumulation to total body fatness.

Authors:  S Lemieux; D Prud'homme; C Bouchard; A Tremblay; J P Després
Journal:  Am J Clin Nutr       Date:  1993-10       Impact factor: 7.045

View more
  11 in total

1.  Hypothalamic obesity in patients with craniopharyngioma: treatment approaches and the emerging role of gastric bypass surgery.

Authors:  Gabrielle Page-Wilson; Sharon L Wardlaw; Alexander G Khandji; Judith Korner
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

Review 2.  Subcutaneous fat loss is greater than visceral fat loss with diet and exercise, weight-loss promoting drugs and bariatric surgery: a critical review and meta-analysis.

Authors:  C Merlotti; V Ceriani; A Morabito; A E Pontiroli
Journal:  Int J Obes (Lond)       Date:  2017-02-02       Impact factor: 5.095

Review 3.  Visceral Adipose Tissue Accumulation and Residual Cardiovascular Risk.

Authors:  Thierry H Le Jemtel; Rohan Samson; Gregory Milligan; Abhishek Jaiswal; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2018-07-10       Impact factor: 5.369

4.  Preoperative nutritional interventions in morbid obesity: impact on body weight, energy intake, and eating quality.

Authors:  Mariana Silva Melendez-Araújo; Sérgio Lincoln de Matos Arruda; Emily de Oliveira Kelly; Kênia Mara Baiocchi de Carvalho
Journal:  Obes Surg       Date:  2012-12       Impact factor: 4.129

5.  Sex Effect on Obesity Indices and Metabolic Outcomes in Patients with Obese Obstructive Sleep Apnea and Type 2 Diabetes After Laparoscopic Roux-en-Y Gastric Bypass Surgery: a Preliminary Study.

Authors:  Huajun Xu; Pin Zhang; Xiaodong Han; Haoyong Yu; Jianzhong Di; Jianyin Zou; Yuyu Wang; Yingjun Qian; Yinfang Tu; Yuqian Bao; Hongliang Yi; Jian Guan; Shankai Yin; Weiping Jia
Journal:  Obes Surg       Date:  2016-11       Impact factor: 4.129

6.  Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes.

Authors:  Sandeep Dhindsa; Husam Ghanim; Manav Batra; Nitesh D Kuhadiya; Sanaa Abuaysheh; Sartaj Sandhu; Kelly Green; Antoine Makdissi; Jeanne Hejna; Ajay Chaudhuri; Mark Punyanitya; Paresh Dandona
Journal:  Diabetes Care       Date:  2015-11-29       Impact factor: 19.112

7.  Comparison of glucostatic parameters after hypocaloric diet or bariatric surgery and equivalent weight loss.

Authors:  Leona Plum; Leaque Ahmed; Gerardo Febres; Marc Bessler; William Inabnet; Elizabeth Kunreuther; Donald J McMahon; Judith Korner
Journal:  Obesity (Silver Spring)       Date:  2011-05-19       Impact factor: 5.002

Review 8.  New obesity classification criteria as a tool for bariatric surgery indication.

Authors:  Antonino De Lorenzo; Laura Soldati; Francesca Sarlo; Menotti Calvani; Nicola Di Lorenzo; Laura Di Renzo
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

9.  Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass.

Authors:  J Korner; W Inabnet; G Febres; I M Conwell; D J McMahon; R Salas; C Taveras; B Schrope; M Bessler
Journal:  Int J Obes (Lond)       Date:  2009-05-05       Impact factor: 5.095

10.  Omentin-1 levels are reduced by pharmacologic doses of leptin, but remain unaffected by energy deprivation and display no day-night variation.

Authors:  Ole-Petter Riksfjord Hamnvik; Bindiya Thakkar; John Chamberland; Konstantinos Aronis; Benjamin Schneider; Christos S Mantzoros
Journal:  Int J Obes (Lond)       Date:  2014-06-20       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.